Amir Kaki, MD, discusses large bore femoral and axillary closure techniques as well as vascular closure devices currently on the market and in the pipeline.
This FAQ discusses the causes, incidence, and diagnosis of right heart failure and how the Impella RP with SmartAssist heart pump can support the right side of the heart.
Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute.
A preponderance of evidence from the FDA cVAD Study, Impella Quality Database and the physician-initiated NSCI study supports the recommendation that placing Impella 2.5® or Impella CP® pre-PCI improves outcomes.
Robert Riley, MD, presents a high-risk PCI case requiring hemodynamic support with the Impella CP® heart pump and intravascular lithotripsy with Shockwave for vascular access.
Seth Bilazarian, MD, discusses the limitations of Schrage, Ibrahim, et al. published in Circulation comparing patients in cardiogenic shock treated with balloon pump and the Impella® heart pump.
The STEMI DTU pilot trial demonstrated for the first time that LV unloading using the Impella CP® heart pump with a 30-minute delay before reperfusion is safe and feasible
Contrast-induced acute kidney injury (AKI) caused by iodinated contrast medium is associated with high morbidity and mortality in at-risk patients.
NPS-1674
This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
